Rosenthal M, Stoecker C, Leidner AJ, Cho BH, et al. Cost-effectiveness of 15-valent or 20-valent pneumococcal conjugate vaccine for U.S. adults aged 65 years and older and adults 19 years and older with underlying conditions. Vaccine 2025;44:126567.
PMID: 39645434